Evoke Wealth’s PAVmed PAVM Stock Holding History

Evoke Wealth’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1	Closed	-$1K	–	1232
2021 Q4	$1K	Hold	1	–	–	﹤0.01%	1142
2021 Q3	$4K	Hold	1	–	–	﹤0.01%	899
2021 Q2	$3K	Hold	1	–	–	﹤0.01%	998
2021 Q1	$2K	Buy	+1	New	+$1.5K	﹤0.01%	1044

Other funds holding PAVM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Evoke Wealth's PAVM Position: Q1 2022 in Review

Evoke Wealth sold out of PAVmed (PAVM) in Q1 2022, closing a stake of 1 share — an estimated $1K sold.

Evoke Wealth first reported a position in PAVM in Q1 2021 and held it in 4 quarters. The position peaked at $4K in Q3 2021. 94 funds tracked by Wall St. Rank hold PAVM as of Q1 2022.

Evoke Wealth reported no remaining PAVmed position as of Q1 2022 after selling out during the quarter.
Evoke Wealth sold 1 PAVmed share in Q1 2022, an estimated $1K.
Evoke Wealth first reported a position in PAVmed in Q1 2021 and held it in 4 quarters.
Evoke Wealth's PAVmed position peaked at $4K in Q3 2021.
94 funds tracked by Wall St. Rank held PAVmed as of Q1 2022.

Based on Evoke Wealth's 13F filing for Q1 2022, filed 10 May 2022.